maltose123的个人主页 - 老虎社区

maltose123

maltose123

暂无个人介绍

IP属地：未知

1关注

0粉丝

0主题

0勋章

2021-03-16

hjjh

抱歉，原内容已删除

2021-03-11

ooo

Dow ends above 32,000 milestone for first time. Here's how it got there

2021-03-09

hi

Bitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps

2021-03-09

mdndhd

Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep

2021-03-09

likpoo

Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578010145980988","uuid":"3578010145980988","gmtCreate":1614916122097,"gmtModify":1614917288879,"name":"maltose123","pinyin":"maltose123","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":325163694,"gmtCreate":1615876909718,"gmtModify":1703494330982,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hjjh","listText":"hjjh","text":"hjjh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325163694","repostId":"1117628563","repostType":4,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321633356,"gmtCreate":1615427447575,"gmtModify":1703488895926,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"ooo","listText":"ooo","text":"ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321633356","repostId":"2118860390","repostType":4,"repost":{"id":"2118860390","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615413960,"share":"https://www.laohu8.com/m/news/2118860390?lang=&edition=full","pubTime":"2021-03-11 06:06","market":"us","language":"en","title":"Dow ends above 32,000 milestone for first time. Here's how it got there","url":"https://stock-news.laohu8.com/highlight/detail?id=2118860390","media":"Dow Jones","summary":"Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n\nThe Dow Jones Industr","content":"<blockquote>\n Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n</blockquote>\n<p>The Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.</p>\n<p>The 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .</p>\n<p>The rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.</p>\n<p>On top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.</p>\n<p>Against that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.</p>\n<p>A rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.</p>\n<p>Specifically, Goldman Sachs <a href=\"https://laohu8.com/S/GS\">$(GS)$</a> was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. <a href=\"https://laohu8.com/S/BA\">$(BA)$</a>, adding 214 points, was the second-best contributor for the price-oriented index.</p>\n<p>Here's a complete list of the leaders and the laggards:</p>\n<table>\n <tbody>\n  <tr>\n   <td>AMGNTicker</td>\n   <td>Point Contribution</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs</td>\n   <td>331.41</td>\n  </tr>\n  <tr>\n   <td>Boeing</td>\n   <td>214.69</td>\n  </tr>\n  <tr>\n   <td>Caterpillar CAT</td>\n   <td>176.53</td>\n  </tr>\n  <tr>\n   <td>American <a href=\"https://laohu8.com/S/EXPR\">Express</a> AXP</td>\n   <td>165.08</td>\n  </tr>\n  <tr>\n   <td>Chevron Corp. CVX</td>\n   <td>139.16</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co. JPM</td>\n   <td>126.72</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co. DIS</td>\n   <td>108.43</td>\n  </tr>\n  <tr>\n   <td>Travelers Cos. Inc. TRV</td>\n   <td>107.31</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MMM\">3M</a> MMM</td>\n   <td>97.31</td>\n  </tr>\n  <tr>\n   <td>Microsoft MSFT</td>\n   <td>92.97</td>\n  </tr>\n  <tr>\n   <td>Intel Corp. INTC</td>\n   <td>66.19</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/V\">Visa</a> V</td>\n   <td>61.58</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>36.71</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc.</td>\n   <td>34.61</td>\n  </tr>\n  <tr>\n   <td>Cisco CSCO</td>\n   <td>21.91</td>\n  </tr>\n  <tr>\n   <td>Coca-Cola Co. KO</td>\n   <td>9.74</td>\n  </tr>\n  <tr>\n   <td>McDonald's Corp. MCD</td>\n   <td>8.75</td>\n  </tr>\n  <tr>\n   <td>Honeywell HON</td>\n   <td>1.97</td>\n  </tr>\n  <tr>\n   <td>Home Depot HD</td>\n   <td>-0.13</td>\n  </tr>\n  <tr>\n   <td>International Business Machines <a href=\"https://laohu8.com/S/IBM\">IBM</a></td>\n   <td>-7.37</td>\n  </tr>\n  <tr>\n   <td>Johnson &amp; Johnson JNJ</td>\n   <td>-8.03</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications VZ</td>\n   <td>-9.54</td>\n  </tr>\n  <tr>\n   <td>Amgen AMGN</td>\n   <td>-26.21</td>\n  </tr>\n  <tr>\n   <td>salesforce.com CRM</td>\n   <td>-39.61</td>\n  </tr>\n  <tr>\n   <td>Nike NKE</td>\n   <td>-48.43</td>\n  </tr>\n  <tr>\n   <td>Merck MRK</td>\n   <td>-60.93</td>\n  </tr>\n  <tr>\n   <td>Apple AAPL</td>\n   <td>-71.98</td>\n  </tr>\n  <tr>\n   <td>Procter &amp; Gamble PG</td>\n   <td>-75.73</td>\n  </tr>\n  <tr>\n   <td>Walmart WMT</td>\n   <td>-95.21</td>\n  </tr>\n  <tr>\n   <td>UnitedHealth Group Inc. UNH</td>\n   <td>-101.52</td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>Source: Dow Jones Market Data</td>\n  </tr>\n </tbody>\n</table>\n<p>Also worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow ends above 32,000 milestone for first time. Here's how it got there</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow ends above 32,000 milestone for first time. Here's how it got there\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-11 06:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n</blockquote>\n<p>The Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.</p>\n<p>The 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .</p>\n<p>The rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.</p>\n<p>On top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.</p>\n<p>Against that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.</p>\n<p>A rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.</p>\n<p>Specifically, Goldman Sachs <a href=\"https://laohu8.com/S/GS\">$(GS)$</a> was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. <a href=\"https://laohu8.com/S/BA\">$(BA)$</a>, adding 214 points, was the second-best contributor for the price-oriented index.</p>\n<p>Here's a complete list of the leaders and the laggards:</p>\n<table>\n <tbody>\n  <tr>\n   <td>AMGNTicker</td>\n   <td>Point Contribution</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs</td>\n   <td>331.41</td>\n  </tr>\n  <tr>\n   <td>Boeing</td>\n   <td>214.69</td>\n  </tr>\n  <tr>\n   <td>Caterpillar CAT</td>\n   <td>176.53</td>\n  </tr>\n  <tr>\n   <td>American <a href=\"https://laohu8.com/S/EXPR\">Express</a> AXP</td>\n   <td>165.08</td>\n  </tr>\n  <tr>\n   <td>Chevron Corp. CVX</td>\n   <td>139.16</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co. JPM</td>\n   <td>126.72</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co. DIS</td>\n   <td>108.43</td>\n  </tr>\n  <tr>\n   <td>Travelers Cos. Inc. TRV</td>\n   <td>107.31</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MMM\">3M</a> MMM</td>\n   <td>97.31</td>\n  </tr>\n  <tr>\n   <td>Microsoft MSFT</td>\n   <td>92.97</td>\n  </tr>\n  <tr>\n   <td>Intel Corp. INTC</td>\n   <td>66.19</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/V\">Visa</a> V</td>\n   <td>61.58</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>36.71</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc.</td>\n   <td>34.61</td>\n  </tr>\n  <tr>\n   <td>Cisco CSCO</td>\n   <td>21.91</td>\n  </tr>\n  <tr>\n   <td>Coca-Cola Co. KO</td>\n   <td>9.74</td>\n  </tr>\n  <tr>\n   <td>McDonald's Corp. MCD</td>\n   <td>8.75</td>\n  </tr>\n  <tr>\n   <td>Honeywell HON</td>\n   <td>1.97</td>\n  </tr>\n  <tr>\n   <td>Home Depot HD</td>\n   <td>-0.13</td>\n  </tr>\n  <tr>\n   <td>International Business Machines <a href=\"https://laohu8.com/S/IBM\">IBM</a></td>\n   <td>-7.37</td>\n  </tr>\n  <tr>\n   <td>Johnson &amp; Johnson JNJ</td>\n   <td>-8.03</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications VZ</td>\n   <td>-9.54</td>\n  </tr>\n  <tr>\n   <td>Amgen AMGN</td>\n   <td>-26.21</td>\n  </tr>\n  <tr>\n   <td>salesforce.com CRM</td>\n   <td>-39.61</td>\n  </tr>\n  <tr>\n   <td>Nike NKE</td>\n   <td>-48.43</td>\n  </tr>\n  <tr>\n   <td>Merck MRK</td>\n   <td>-60.93</td>\n  </tr>\n  <tr>\n   <td>Apple AAPL</td>\n   <td>-71.98</td>\n  </tr>\n  <tr>\n   <td>Procter &amp; Gamble PG</td>\n   <td>-75.73</td>\n  </tr>\n  <tr>\n   <td>Walmart WMT</td>\n   <td>-95.21</td>\n  </tr>\n  <tr>\n   <td>UnitedHealth Group Inc. UNH</td>\n   <td>-101.52</td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>Source: Dow Jones Market Data</td>\n  </tr>\n </tbody>\n</table>\n<p>Also worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","AAPL":"苹果","BA":"波音","09086":"华夏纳指-U","JNJ":"强生","03086":"华夏纳指"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118860390","content_text":"Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n\nThe Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.\nThe 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .\nThe rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.\nOn top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.\nAgainst that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.\nA rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.\nSpecifically, Goldman Sachs $(GS)$ was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. $(BA)$, adding 214 points, was the second-best contributor for the price-oriented index.\nHere's a complete list of the leaders and the laggards:\n\n\n\nAMGNTicker\nPoint Contribution\n\n\nGoldman Sachs\n331.41\n\n\nBoeing\n214.69\n\n\nCaterpillar CAT\n176.53\n\n\nAmerican Express AXP\n165.08\n\n\nChevron Corp. CVX\n139.16\n\n\nJPMorgan Chase & Co. JPM\n126.72\n\n\nWalt Disney Co. DIS\n108.43\n\n\nTravelers Cos. Inc. TRV\n107.31\n\n\n3M MMM\n97.31\n\n\nMicrosoft MSFT\n92.97\n\n\nIntel Corp. INTC\n66.19\n\n\nVisa V\n61.58\n\n\nDow Inc. DOW\n36.71\n\n\nWalgreens Boots Alliance Inc.\n34.61\n\n\nCisco CSCO\n21.91\n\n\nCoca-Cola Co. KO\n9.74\n\n\nMcDonald's Corp. MCD\n8.75\n\n\nHoneywell HON\n1.97\n\n\nHome Depot HD\n-0.13\n\n\nInternational Business Machines IBM\n-7.37\n\n\nJohnson & Johnson JNJ\n-8.03\n\n\nVerizon Communications VZ\n-9.54\n\n\nAmgen AMGN\n-26.21\n\n\nsalesforce.com CRM\n-39.61\n\n\nNike NKE\n-48.43\n\n\nMerck MRK\n-60.93\n\n\nApple AAPL\n-71.98\n\n\nProcter & Gamble PG\n-75.73\n\n\nWalmart WMT\n-95.21\n\n\nUnitedHealth Group Inc. UNH\n-101.52\n\n\n\nSource: Dow Jones Market Data\n\n\n\nAlso worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329448803,"gmtCreate":1615274765702,"gmtModify":1703486579307,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329448803","repostId":"1120347289","repostType":4,"repost":{"id":"1120347289","pubTimestamp":1615269642,"share":"https://www.laohu8.com/m/news/1120347289?lang=&edition=full","pubTime":"2021-03-09 14:00","market":"fut","language":"en","title":"Bitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=1120347289","media":"cnbc","summary":"KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurre","content":"<div>\n<p>KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","TSLA":"特斯拉","GBTC":"Grayscale Bitcoin Trust"},"source_url":"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1120347289","content_text":"KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 trillion in mid-morning trade Singapore time.\nIt is only the second time that bitcoin’s value has surpassed a $1 trillion after hitting that milestone for the first time on Feb. 19.\n\nBitcoin’s value surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 trillion in mid-morning trade Singapore time, according to CoinDesk.\nBitcoin extended those gains hitting a 24-hour high of $54,348.57 in early afternoon Singapore time, around 7% higher than the same time a day before. Bitcoin has since pared some of those gains.\nIt is only the second time that bitcoin’s value has surpassed a $1 trillion after hitting that milestone for the first time on Feb. 19. Bitcoin’s market capitalization held above $1 trillion for a few days, before falling below that mark.\nEven though bitcoin is sitting off of its all-time-high of $58,332.36, it has seen a huge rally. The digital currency is up over 80% this year and 570% higher over the last 12 months.\nBitcoin’s rally has been attributed to several factors including participation from larger institutional investors and some notable purchases from corporations.Tesla,Square and Microstrategy area mong the companies that have purchased bitcoin.\nOn Sunday, a Chinese appmaker called Meitu said that it had purchased not only bitcoin, but another cryptocurrency called ether too.Ether, a cryptocurrency which runs on the Ethereum network, was trading at $1,836.73 at around 10:41 a.m. Singapore time, up nearly 7% from a day before, according to CoinDesk.\nCompanies are also making acquisitions in the cryptocurrency space.PayPal on Monday said it will buy cryptocurrency security firm Curv.\nProponents of bitcoin often liken it to “digital gold,” a hedge against inflation and potential “safe-haven” asset where investors can park their money in times of political or economic turmoil.\nSome argue that loose monetary policy such as low interest rates and asset purchases by central banks around the world erodes the value of fiat currencies like the U.S. dollar and bitcoin provides a better alternative to invest in.","news_type":1},"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457469,"gmtCreate":1615274030751,"gmtModify":1703486572250,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"&nbsp;mdndhd","listText":"&nbsp;mdndhd","text":"mdndhd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329457469","repostId":"1168910610","repostType":4,"repost":{"id":"1168910610","pubTimestamp":1615272511,"share":"https://www.laohu8.com/m/news/1168910610?lang=&edition=full","pubTime":"2021-03-09 14:48","market":"us","language":"en","title":"Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep","url":"https://stock-news.laohu8.com/highlight/detail?id=1168910610","media":"seekingalpha","summary":"Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from t","content":"<p>Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in healthy volunteers.</p><p>Healthy volunteers were randomized 3:1 to receive ensovibep or placebo, respectively.</p><p>Two dosing cohorts with 8 patients per dose cohort have been fully enrolled and received a single infusion of 3mg or 9mg per kilogram body weight.</p><p>In each of these cohorts, ensovibep was seen to be safe and well tolerated, with no significant adverse events reported.</p><p>Preliminary results showed extended exposure of the DARPin candidate in serum, with a half-life of 2-3 weeks.</p><p>These data support advanced plans for additional clinical work in positively diagnosed patients.</p><p>The companies looks forward to initiate phase 2/3 global registration study, early in Q2.</p><p>Per protocol, a third cohort at a 20mg per kilogram dose level has been planned.</p><p>In October 2020, Molecular Partners and Novartis collaborated to developtwo DARPin therapies for COVID-19.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 14:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in...</p>\n\n<a href=\"https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVS":"诺华","MLLCF":"Molecular Partners AG"},"source_url":"https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1168910610","content_text":"Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in healthy volunteers.Healthy volunteers were randomized 3:1 to receive ensovibep or placebo, respectively.Two dosing cohorts with 8 patients per dose cohort have been fully enrolled and received a single infusion of 3mg or 9mg per kilogram body weight.In each of these cohorts, ensovibep was seen to be safe and well tolerated, with no significant adverse events reported.Preliminary results showed extended exposure of the DARPin candidate in serum, with a half-life of 2-3 weeks.These data support advanced plans for additional clinical work in positively diagnosed patients.The companies looks forward to initiate phase 2/3 global registration study, early in Q2.Per protocol, a third cohort at a 20mg per kilogram dose level has been planned.In October 2020, Molecular Partners and Novartis collaborated to developtwo DARPin therapies for COVID-19.","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457280,"gmtCreate":1615274014440,"gmtModify":1703486572078,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"likpoo","listText":"likpoo","text":"likpoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329457280","repostId":"2118923226","repostType":4,"repost":{"id":"2118923226","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615271378,"share":"https://www.laohu8.com/m/news/2118923226?lang=&edition=full","pubTime":"2021-03-09 14:29","market":"us","language":"en","title":"Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study","url":"https://stock-news.laohu8.com/highlight/detail?id=2118923226","media":"Reuters","summary":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutr","content":"<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118923226","content_text":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.\nBlood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.\nThe scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.\nThe spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.\nIn previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.\nPfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.","news_type":1},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":325163694,"gmtCreate":1615876909718,"gmtModify":1703494330982,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hjjh","listText":"hjjh","text":"hjjh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325163694","repostId":"1117628563","repostType":4,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321633356,"gmtCreate":1615427447575,"gmtModify":1703488895926,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"ooo","listText":"ooo","text":"ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321633356","repostId":"2118860390","repostType":4,"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329448803,"gmtCreate":1615274765702,"gmtModify":1703486579307,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329448803","repostId":"1120347289","repostType":4,"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457469,"gmtCreate":1615274030751,"gmtModify":1703486572250,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"&nbsp;mdndhd","listText":"&nbsp;mdndhd","text":"mdndhd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329457469","repostId":"1168910610","repostType":4,"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457280,"gmtCreate":1615274014440,"gmtModify":1703486572078,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"likpoo","listText":"likpoo","text":"likpoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/329457280","repostId":"2118923226","repostType":4,"repost":{"id":"2118923226","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615271378,"share":"https://www.laohu8.com/m/news/2118923226?lang=&edition=full","pubTime":"2021-03-09 14:29","market":"us","language":"en","title":"Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study","url":"https://stock-news.laohu8.com/highlight/detail?id=2118923226","media":"Reuters","summary":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutr","content":"<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118923226","content_text":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.\nBlood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.\nThe scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.\nThe spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.\nIn previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.\nPfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.","news_type":1},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}